The estimated Net Worth of Geoffrey Mackay is at least $2.42 Million dollars as of 28 December 2022. Geoffrey Mackay owns over 45,999 units of AvroBio Inc stock worth over $263,217 and over the last 6 years Geoffrey sold AVRO stock worth over $2,159,108.
Geoffrey has made over 6 trades of the AvroBio Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Geoffrey exercised 45,999 units of AVRO stock worth $41,859 on 28 December 2022.
The largest trade Geoffrey's ever made was exercising 142,013 units of AvroBio Inc stock on 23 December 2022 worth over $58,225. On average, Geoffrey trades about 28,186 units every 105 days since 2019. As of 28 December 2022 Geoffrey still owns at least 188,012 units of AvroBio Inc stock.
You can see the complete history of Geoffrey Mackay stock trades at the bottom of the page.
Geoffrey's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.
Over the last 6 years, insiders at AvroBio Inc have traded over $3,066,308 worth of AvroBio Inc stock and bought 2,395,057 units worth $31,037,133 . The most active insiders traders include Braden Michael Leonard, Bruce Booth und Venture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of $206,675. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth $973,626.
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
AvroBio Inc executives and other stock owners filed with the SEC include: